Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 1

The emerging roles of ADAMTS-7 and ADAMTS-12 matrix metalloproteinases

Authors Lin EA, Liu C

Published 23 September 2009 Volume 2009:1 Pages 121—131


Review by Single anonymous peer review

Peer reviewer comments 4

Edward A Lin1, Chuan-ju Liu1,2

1Department of Orthopaedic Surgery, 2Department of Cell Biology, New York University School of Medicine, New York, NY, USA

Abstract: The a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) comprise a family of secreted zinc metalloproteinases with a precisely ordered modular organization. These enzymes play an important role in the turnover of extracellular matrix proteins in various tissues and their dysregulation has been implicated in disease-related processes such as arthritis, atherosclerosis, cancer, and inflammation. ADAMTS-7 and ADAMTS-12 share a similar domain organization to each other and form a subgroup within the ADAMTS family. Emerging evidence suggests that ADAMTS-7 and ADAMTS-12 may play an important role in the development and pathogenesis of various kinds of diseases. In this review, we summarize what is currently known about the roles of these two metalloproteinases, with a special focus on their involvement in chondrogenesis, endochondral ossification, and the pathogenesis of arthritis, atherosclerosis, and cancer. The future study of ADAMTS-7 and ADAMTS-12, as well as the molecules with which they interact, will help us to better understand a variety of human diseases from both a biological and therapeutic standpoint.

Keywords: ADAMTS-7, ADAMTS-12, COMP, GEP, arthritis, chondrogenesis, atherosclerosis

Creative Commons License © 2009 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.